Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-01-16 SCHABER CHRISTOPHER J Chairman CEO and President Grant or award +333,333 805,150
2011-12-01 SCHABER CHRISTOPHER J Chairman CEO and President Grant or award · Stock Option (Right to Buy) +2,400,000 2,400,000
2011-12-01 MYRIANTHOPOULOS EVAN Sr VP and CFO Grant or award · Stock Option (Right to Buy) +1,200,000 1,200,000
2011-12-01 HORGAN KEVIN Sr VP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +1,200,000 1,200,000
2011-12-01 BREY ROBERT N Sr VP & Chief Science Officer Grant or award · Stock Option (Right to Buy) +700,000 700,000
2011-12-01 Warusz Joseph Michael VP of Admin, Controller Grant or award · Stock Option (Right to Buy) +600,000 600,000
2011-06-22 THOMPSON VIRGIL Director Grant or award · Stock Option (Right to Buy) +191,722 191,722
2011-06-22 RUBIN ROBERT J. Director Grant or award · Stock Option (Right to Buy) +191,722 191,722
2011-06-22 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +191,722 191,722
2011-06-22 HOWSON TAMAR D Director Grant or award · Stock Option (Right to Buy) +191,722 191,722
2011-06-22 ZELDIS JEROME B Director Grant or award · Stock Option (Right to Buy) +300,000 300,000
2011-06-22 Brownlie Keith L Director Grant or award · Stock Option (Right to Buy) +300,000 300,000
2011-05-31 Warusz Joseph Michael VP of Admin, Controller Grant or award · Stock Option (Right to Buy) +800,000
2011-01-31 HORGAN KEVIN Senior VP; Chief Med Officer Grant or award · Stock Option (Right to Buy) +1,250,000 1,250,000
2010-09-23 SCHNITTKER CHRISTOPHER P. VP-Admin., Controller Grant or award · Stock Option (Right to Buy) +700,000 700,000
2010-09-23 HAMILTON BRIAN L Chief Medical Officer & Sr VP Grant or award · Stock Option (Right to Buy) +800,000 800,000
2010-09-23 BREY ROBERT N Chief Science Officer & Sr VP Grant or award · Stock Option (Right to Buy) +850,000 850,000

Page 14 of 14 · 277 trades